176 related articles for article (PubMed ID: 22752328)
1. Rewarding and incentive motivational effects of excitatory amino acid receptor antagonists into the median raphe and adjacent regions of the rat.
Webb SM; Vollrath-Smith FR; Shin R; Jhou TC; Xu S; Ikemoto S
Psychopharmacology (Berl); 2012 Dec; 224(3):401-12. PubMed ID: 22752328
[TBL] [Abstract][Full Text] [Related]
2. The GABAB receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats.
Shin R; Ikemoto S
Psychopharmacology (Berl); 2010 Mar; 208(4):545-54. PubMed ID: 20054525
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction between baclofen administration into the median raphe nucleus and inconsequential visual stimuli on investigatory behavior of rats.
Vollrath-Smith FR; Shin R; Ikemoto S
Psychopharmacology (Berl); 2012 Mar; 220(1):15-25. PubMed ID: 21904820
[TBL] [Abstract][Full Text] [Related]
4. Concurrent antagonism of NMDA and AMPA receptors in the ventral tegmental area reduces the expression of conditioned approach learning in rats.
Hachimine P; Seepersad N; Babic S; Ranaldi R
Behav Brain Res; 2016 Feb; 298(Pt B):142-9. PubMed ID: 26542814
[TBL] [Abstract][Full Text] [Related]
5. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
Gartside SE; Cole AJ; Williams AP; McQuade R; Judge SJ
Eur J Neurosci; 2007 May; 25(10):3001-8. PubMed ID: 17509083
[TBL] [Abstract][Full Text] [Related]
6. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
7. Rewarding effects elicited by the microinjection of either AMPA or NMDA glutamatergic antagonists into the ventral tegmental area revealed by an intracranial self-administration paradigm in mice.
David V; Durkin TP; Cazala P
Eur J Neurosci; 1998 Apr; 10(4):1394-402. PubMed ID: 9749793
[TBL] [Abstract][Full Text] [Related]
8. The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor.
Laviolette SR; van der Kooy D
Psychopharmacology (Berl); 2003 Mar; 166(3):306-13. PubMed ID: 12569428
[TBL] [Abstract][Full Text] [Related]
9. Enhanced AMPA receptor activity increases operant alcohol self-administration and cue-induced reinstatement.
Cannady R; Fisher KR; Durant B; Besheer J; Hodge CW
Addict Biol; 2013 Jan; 18(1):54-65. PubMed ID: 23126443
[TBL] [Abstract][Full Text] [Related]
10. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
Tan SE
Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
[TBL] [Abstract][Full Text] [Related]
11. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior.
Di Ciano P; Cardinal RN; Cowell RA; Little SJ; Everitt BJ
J Neurosci; 2001 Dec; 21(23):9471-7. PubMed ID: 11717381
[TBL] [Abstract][Full Text] [Related]
13. NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats.
Biondo AM; Clements RL; Hayes DJ; Eshpeter B; Greenshaw AJ
Psychopharmacology (Berl); 2005 Apr; 179(1):189-97. PubMed ID: 15744543
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor blockade in the prelimbic cortex activates the mesolimbic system and dopamine-dependent opiate reward signaling.
Tan H; Rosen LG; Ng GA; Rushlow WJ; Laviolette SR;
Psychopharmacology (Berl); 2014 Dec; 231(24):4669-79. PubMed ID: 24871699
[TBL] [Abstract][Full Text] [Related]
15. [The effect of the NMDA-receptor antagonist (+/-)-CPP on the conditioned-reflex activation of an operant reaction in the brain electrical self-stimulation test in rats].
Bespalov AIu; Evartau EE
Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(1):117-21. PubMed ID: 8693775
[TBL] [Abstract][Full Text] [Related]
16. NMDA and AMPA/kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by GABAA receptor blockade in the medial hypothalamus.
de Freitas RL; Salgado-Rohner CJ; Biagioni AF; Medeiros P; Hallak JE; Crippa JA; Coimbra NC
Cereb Cortex; 2014 Jun; 24(6):1518-28. PubMed ID: 23349224
[TBL] [Abstract][Full Text] [Related]
17. Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats.
Nakamura K; Kurasawa M; Shirane M
Brain Res; 2000 Apr; 862(1-2):266-9. PubMed ID: 10799697
[TBL] [Abstract][Full Text] [Related]
18. Effects of a systemic AMPA/KA and NMDA receptor blockade on pavlovian-instrumental transfer.
Murschall A; Hauber W
Psychopharmacology (Berl); 2005 Oct; 182(2):290-6. PubMed ID: 16001115
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala.
Kenny PJ; Chartoff E; Roberto M; Carlezon WA; Markou A
Neuropsychopharmacology; 2009 Jan; 34(2):266-81. PubMed ID: 18418357
[TBL] [Abstract][Full Text] [Related]
20. AMPA receptor antagonists reverse effects of extended habit training on signaled food approach responding in rats.
Bespalov AY; Harich S; Jongen-Rêlo AL; van Gaalen MM; Gross G
Psychopharmacology (Berl); 2007 Nov; 195(1):11-8. PubMed ID: 17634927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
